This is an editorial summary of research originally reported by The Lancet. ProductSafer does not claim ownership of the underlying research. All intellectual property belongs to the original publishers.
Free weekly digest
We track health and safety research on food, cosmetics, and household products and send you what matters. Join 27 readers.
What would you like to do next?
I use this product
Get the next safety alert before it goes viral
Free weekly digest of health findings about everyday products. No spam, unsubscribe any time.
Advertisement
Get the latest health findings delivered to your inbox. Only the important stuff. No spam.
We'll send a confirmation email. Unsubscribe anytime.
The US government removed hepatitis A vaccine from routine childhood immunizations in January 2026, moving it only to high-risk groups. Without universal vaccination, hepatitis A outbreaks could spread more easily among children and vulnerable populations. Experts warn that this change risks reversing decades of progress in preventing this serious liver infection.
# Editorial Summary
In early 2026, U.S. health authorities made a significant policy shift by removing several vaccines, including hepatitis A protection, from the list of routine vaccines recommended for all children. Under the new guidance, hepatitis A vaccination is now primarily recommended only for children considered at higher risk rather than as a universal childhood vaccine. This change marks a departure from decades of public health strategy aimed at preventing hepatitis A outbreaks across the general population.
Hepatitis A is a viral infection that affects the liver and spreads through contaminated food and water or close contact with infected individuals. While most people recover fully from hepatitis A, the infection can cause severe illness, particularly in older adults and people with existing liver disease. Before hepatitis A vaccine became a routine childhood immunization, the virus caused thousands of cases annually in the United States. The vaccine has been credited with dramatically reducing hepatitis A cases over the past two decades.
The rationale behind removing hepatitis A from universal vaccination recommendations reflects a shift in risk assessment by federal health agencies including the CDC, FDA, and NIH. However, public health experts have expressed concern that moving away from universal childhood vaccination could allow hepatitis A to resurface in communities, particularly among unvaccinated children and vulnerable populations who may not qualify as "high risk" under the new guidelines.
For parents and caregivers, it's important to discuss hepatitis A vaccination with your child's doctor, even if it's no longer automatically recommended. Ask whether your child should receive the vaccine based on your family's circumstances, travel plans, or community health status. If you have questions about whether hepatitis A protection is right for your child, your healthcare provider can help you make an informed decision based on current risk factors in your area.
Always consult a healthcare professional for personal medical advice.
Read the full report at the original source
The LancetWas this finding useful?
Community discussion
Join the discussion
Comments are reviewed before appearing publicly.